ZA200306402B - Combined vaccine compositions. - Google Patents

Combined vaccine compositions.

Info

Publication number: ZA200306402B
Authority: ZA; South Africa
Prior art keywords: vaccine compositions; combined vaccine; combined; compositions; vaccine
Prior art date: 1999-09-07

Application number

ZA200306402A

Other languages

English (en)

Inventor

Wettendorff Martine Ann Cecile

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-07

Filing date

2000-09-07

Publication date

2004-08-02

2000-09-07 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

2004-08-02 Publication of ZA200306402B publication Critical patent/ZA200306402B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- B—PERFORMING OPERATIONS; TRANSPORTING
- B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
- B09C—RECLAMATION OF CONTAMINATED SOIL
- B09C1/00—Reclamation of contaminated soil
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02D—FOUNDATIONS; EXCAVATIONS; EMBANKMENTS; UNDERGROUND OR UNDERWATER STRUCTURES
- E02D3/00—Improving or preserving soil or rock, e.g. preserving permafrost soil
- E02D3/11—Improving or preserving soil or rock, e.g. preserving permafrost soil by thermal, electrical or electro-chemical means
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Soil Sciences (AREA)
Environmental & Geological Engineering (AREA)
Structural Engineering (AREA)
Molecular Biology (AREA)
Oncology (AREA)
General Life Sciences & Earth Sciences (AREA)
Biophysics (AREA)
Mining & Mineral Resources (AREA)
Paleontology (AREA)
Civil Engineering (AREA)
Agronomy & Crop Science (AREA)
General Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

ZA200306402A 1999-09-07 2000-09-07 Combined vaccine compositions. ZA200306402B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9921146A GB9921146D0 (en)	1999-09-07	1999-09-07	Novel composition

Publications (1)

Publication Number	Publication Date
ZA200306402B true ZA200306402B (en)	2004-08-02

Family

ID=10860520

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ZA200306402A ZA200306402B (en)	1999-09-07	2000-09-07	Combined vaccine compositions.
ZA200201810A ZA200201810B (en)	1999-09-07	2002-03-05	Combined vaccine compositions.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
ZA200201810A ZA200201810B (en)	1999-09-07	2002-03-05	Combined vaccine compositions.

Country Status (33)

Country	Link
US (3)	US6936255B1 (xx)
EP (3)	EP1210113B1 (xx)
JP (2)	JP4689910B2 (xx)
KR (2)	KR100557665B1 (xx)
CN (2)	CN100389824C (xx)
AR (1)	AR025502A1 (xx)
AT (2)	ATE312624T1 (xx)
AU (1)	AU766494B2 (xx)
BR (1)	BR0014171A (xx)
CA (2)	CA2443214C (xx)
CO (1)	CO5280045A1 (xx)
CY (2)	CY1107457T1 (xx)
CZ (2)	CZ2002843A3 (xx)
DE (2)	DE60027029T2 (xx)
DK (2)	DK1410805T3 (xx)
ES (2)	ES2253636T3 (xx)
GB (1)	GB9921146D0 (xx)
GC (1)	GC0000201A (xx)
HK (1)	HK1048435B (xx)
HU (2)	HU229099B1 (xx)
IL (3)	IL148456A0 (xx)
MX (1)	MXPA02002484A (xx)
MY (2)	MY130084A (xx)
NO (3)	NO332800B1 (xx)
NZ (2)	NZ527560A (xx)
PL (2)	PL201264B1 (xx)
PT (1)	PT1210113E (xx)
SG (1)	SG110072A1 (xx)
SI (2)	SI1410805T1 (xx)
TR (1)	TR200200607T2 (xx)
TW (1)	TWI258374B (xx)
WO (1)	WO2001017551A2 (xx)
ZA (2)	ZA200306402B (xx)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6207646B1 (en)	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
US20060029617A1 (en) *	1997-10-03	2006-02-09	Charreyre Catherine E	Porcine circovirus and Helicobacter combination vaccines and methods of use
FR2772047B1 (fr)	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
ES2628744T3 (es)	1998-05-22	2017-08-03	Ottawa Hospital Research Institute	Métodos y productos para inducir inmunidad en mucosas
CA2773698C (en)	1998-10-16	2015-05-19	Glaxosmithkline Biologicals S.A.	Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof
US20050002958A1 (en) *	1999-06-29	2005-01-06	Smithkline Beecham Biologicals Sa	Vaccines
GB9921147D0 (en)	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
ATE354662T1 (de)	2001-03-23	2007-03-15	Deutsches Krebsforsch	Modifizierte hpv e6- und e7-gene und -proteine als impfstoff
GB0110431D0 (en) *	2001-04-27	2001-06-20	Glaxosmithkline Biolog Sa	Novel compounds
GB0206360D0 (en) *	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
CA2486450C (en) †	2002-05-17	2013-11-19	University Of Cape Town	Chimaeric human papillomavirus 16 l1 virus-like particles and method for preparing the particles
CA2484941A1 (en)	2002-07-24	2004-02-05	Intercell Ag	Antigens encoded by alternative reading frame from pathogenic viruses
AU2003258672B2 (en)	2002-09-13	2008-10-30	Intercell Ag	Method for isolating hepatitis C virus peptides
BR0315810A (pt)	2002-10-29	2005-09-13	Coley Pharmaceutical Group Ltd	Uso de oligonucleotìdeos cpg no tratamento de infecção por vìrus da hepatite c
AU2003300919A1 (en)	2002-12-11	2004-06-30	Coley Pharmaceutical Gmbh	5' cpg nucleic acids and methods of use
ATE503492T1 (de) *	2002-12-20	2011-04-15	Glaxosmithkline Biolog Sa	Verwendung von hpv16 und hpv18 vlps als vakzine gegen eine oder mehrere onkogene hpv des typus 31,33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
US7858098B2 (en) *	2002-12-20	2010-12-28	Glaxosmithkline Biologicals, S.A.	Vaccine
CN100418577C (zh) *	2002-12-20	2008-09-17	葛兰素史密丝克莱恩生物有限公司	Hpv-16和hpv-18l1vlp疫苗
EP2345420B1 (en) *	2003-03-24	2016-01-06	Valneva Austria GmbH	Use of a TH1 immune response inducing adjuvant for enhancing immune responses
ES2351489T3 (es) *	2003-03-24	2011-02-07	Intercell Ag	Vacunas mejoradas.
US7758866B2 (en) *	2004-06-16	2010-07-20	Glaxosmithkline Biologicals, S.A.	Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
GB0413510D0 (en) *	2004-06-16	2004-07-21	Glaxosmithkline Biolog Sa	Vaccine
WO2005123125A1 (en) *	2004-06-16	2005-12-29	Glaxosmithkline Biologicals S.A.	Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
AP2007004151A0 (en) *	2005-02-16	2007-10-31	Norvatis Vaccines And Diagnost	Adjuvant composition comprising aluminium phosphate and 3D-MPL
JP4182074B2 (ja)	2005-03-03	2008-11-19	ファナック株式会社	ハンド及びハンドリングロボット
KR20070116652A (ko) *	2005-03-23	2007-12-10	글락소스미스클라인 바이오로지칼즈 에스.에이.	Ｃｄ4 ｔ－세포 및/또는 개선된 ｂ－메모리 세포 반응을유도하는 인플루엔자 바이러스 및 수중유 에멀젼애주번트의 용도
WO2006114312A2 (en) *	2005-04-26	2006-11-02	Glaxosmithkline Biologicals S.A.	Vaccine
CA2606206A1 (en) *	2005-04-26	2006-11-02	Glaxosmithkline Biologicals S.A.	Vaccine
US7790203B2 (en) *	2005-12-13	2010-09-07	Lowder Tom R	Composition and regimen for the treatment of herpes simplex virus, herpes zoster, and herpes genitalia epidermal herpetic lesions
TWI457133B (zh)	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	新穎組合物
AU2006330491B2 (en)	2005-12-29	2011-08-18	Boehringer Ingelheim Animal Health USA Inc.	Multivalent PCV2 immunogenic compositions and methods of producing such compositions
DK3127551T3 (da)	2005-12-29	2020-10-12	Boehringer Ingelheim Animal Health Usa Inc	Pcv2-immunogen-sammensætning til at mindske kliniske symptomer i grise
US20090246220A1 (en) *	2006-08-28	2009-10-01	Ertl Hildegund C J	Constructs for enhancing immune responses
US20090181078A1 (en)	2006-09-26	2009-07-16	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
LT2484375T (lt)	2006-09-26	2018-07-10	Infectious Disease Research Institute	Vakcinos kompozicija, turinti sintetinio adjuvanto
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
EP2129394B1 (en)	2007-03-09	2012-06-20	Merck Sharp & Dohme Corp.	Papillomavirus vaccine compositions
WO2009001867A1 (ja) *	2007-06-26	2008-12-31	Japan Health Sciences Foundation	高リスク群ヒトパピローマウイルスに対する交差性中和抗体を誘導するワクチン抗原
US7829274B2 (en)	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
CN102112153B (zh)	2008-06-04	2014-04-16	一般财团法人化学及血清疗法研究所	灭活日本脑炎病毒颗粒作为佐剂的用途
JP6022159B2 (ja) *	2008-07-31	2016-11-09	グラクソスミスクラインバイオロジカルズソシエテアノニム	抗ｈｐｖワクチン
WO2010135749A1 (en)	2009-05-22	2010-11-25	Genocea Biosciences Inc.	Herpes simplex virus type2: compositions and methods for eliciting an immune response
LT2437753T (lt)	2009-06-05	2016-12-12	Infectious Disease Research Institute	Sintetiniai gliukopiranozillipidų adjuvantai ir juos turinčios vakcinų kompozicijos
PL2444103T3 (pl) *	2009-06-19	2018-05-30	Eyegene Inc.	Szczepionka przeciwko rakowi szyjki macicy
AU2010264695A1 (en) *	2009-06-25	2012-01-19	Glaxosmithkline Biologicals S.A.	Novel human papillomavirus (HPV) protein constructs and their use in the prevention of HPV disease
AR078253A1 (es)	2009-09-02	2011-10-26	Boehringer Ingelheim Vetmed	Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
CN103025351B (zh) *	2010-05-28	2016-08-24	佐蒂斯比利时股份有限公司	包含胆固醇和作为唯一的佐剂-载剂分子的cpg的疫苗
UA112970C2 (uk) *	2010-08-05	2016-11-25	Мерк Шарп Енд Доме Корп.	Інактивований вірус вітряної віспи, спосіб його одержання і застосування
CN103154737B (zh) *	2010-08-27	2015-07-15	英特维特国际股份有限公司	疫苗制剂的效价测试
CN102008721A (zh) *	2010-11-16	2011-04-13	浙江大学	一种hpv多肽/dc混合疫苗及其制备
AU2011336894B2 (en)	2010-11-24	2016-11-17	Genocea Biosciences, Inc.	Vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
WO2012141984A1 (en)	2011-04-08	2012-10-18	Immune Design Corp.	Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
CN102210858B (zh) *	2011-05-18	2013-05-08	北京科兴生物制品有限公司	一种肠道病毒71型与甲型肝炎联合疫苗
CA2834618C (en)	2011-06-24	2020-11-03	Merck Sharp & Dohme Corp.	Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same
WO2013006569A2 (en) *	2011-07-01	2013-01-10	The Regents Of The University Of California	Herpes virus vaccine and methods of use
EP2782597B1 (en)	2011-11-23	2022-04-13	Genocea Biosciences, Inc.	Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
EP2811981B1 (en)	2012-02-07	2019-05-08	Infectious Disease Research Institute	Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
EA034351B1 (ru)	2012-05-16	2020-01-30	Иммьюн Дизайн Корп.	Трехкомпонентная вакцина против впг-2 и способы ее применения
US9624510B2 (en)	2013-03-01	2017-04-18	The Wistar Institute	Adenoviral vectors comprising partial deletions of E3
HK1214510A1 (zh)	2013-04-18	2016-07-29	Immune Design Corp.	用於癌症治疗的gla单一疗法
US9463198B2 (en)	2013-06-04	2016-10-11	Infectious Disease Research Institute	Compositions and methods for reducing or preventing metastasis
IL310015B1 (en)	2013-12-31	2025-10-01	Access To Advanced Health Inst	Single vial formulation
AU2017305176B2 (en)	2016-08-01	2021-05-27	The Wistar Institute Of Anatomy And Biology	Compositions and methods of replication deficient adenoviral vectors for vaccine applications
WO2018064232A1 (en)	2016-09-28	2018-04-05	Genocea Biosciences, Inc.	Methods and compositions for treating herpes
CN107987159B (zh) *	2017-11-28	2021-06-22	上海药明生物医药有限公司	一种使用大剂量dna免疫技术免疫动物使血清中抗体滴度提高的方法
GB201821207D0 (en) *	2018-12-24	2019-02-06	Tcer Ab	Immunotherapy therapy
WO2020243115A1 (en)	2019-05-25	2020-12-03	Infectious Disease Research Institute	Composition and method for spray drying an adjuvant vaccine emulsion
CN110652980B (zh) *	2019-10-09	2020-06-30	北京尚华生态环保科技股份公司	一种土壤原位修复剂
CN110576034B (zh) *	2019-10-09	2020-06-30	北京尚华生态环保科技股份公司	一种土壤原位修复方法
US20220396797A1 (en)	2019-11-15	2022-12-15	Infectious Disease Research Institute	Rig-i agonist and adjuvant formulation for tumor treatment
CN114681602B (zh) *	2020-12-25	2023-12-01	中国食品药品检定研究院	一种双价人乳头瘤病毒疫苗
CN114796479A (zh) *	2022-06-02	2022-07-29	金宇保灵生物药品有限公司	一种畜类动物疫苗用水包油包水佐剂及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH085804B2 (ja)	1988-04-28	1996-01-24	財団法人化学及血清療法研究所	Ａ型及びｂ型肝炎混合アジュバントワクチン
GB9113809D0 (en) *	1991-06-26	1991-08-14	Cancer Res Campaign Tech	Papillomavirus l2 protein
DE122007000085I1 (de) *	1991-07-19	2008-03-27	Univ Queensland St Lucia	Polynukleotidabschnitt des HPV16-Genoms
US5618536A (en) *	1992-09-03	1997-04-08	The United States Of America As Represented By The Department Of Health And Human Services	Chimeric papillomavirus-like particles
US5437951A (en) *	1992-09-03	1995-08-01	The United States Of America As Represented By The Department Of Health And Human Services	Self-assembling recombinant papillomavirus capsid proteins
EP1175912A1 (en) *	1993-03-23	2002-01-30	SmithKline Beecham Biologics SA	Vaccine compositions containing 3-O deacylated monophosphoryl lipid A
GB9326253D0 (en) *	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
GB9409962D0 (en) *	1994-05-18	1994-07-06	Smithkline Beecham Biolog	Novel compounds
AU4727296A (en) *	1995-02-24	1996-09-11	Cantab Pharmaceuticals Research Limited	Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
JP2000506376A (ja) *	1996-01-26	2000-05-30	イノジェネティックス・ナムローゼ・フェンノートシャップ	トキソプラズマ・ゴンジイ抗原Ｔｇ２０
NZ331164A (en) *	1996-02-09	2000-02-28	Univ Liege	Vaccines against varicella zoster virus gene 63 product
GB9711990D0 (en) *	1997-06-11	1997-08-06	Smithkline Beecham Biolog	Vaccine
GB9717953D0 (en) *	1997-08-22	1997-10-29	Smithkline Beecham Biolog	Vaccine
CA2229955C (en) *	1998-02-20	2003-12-09	Medigene Gmbh	Papilloma virus capsomere vaccine formulations and methods of use
BR9908599A (pt) *	1998-03-09	2000-11-14	Smithkline Beecham Biolog	Composições combinadas de vacina
US6500284B1 (en)	1998-06-10	2002-12-31	Suraltech, Inc.	Processes for continuously producing fine grained metal compositions and for semi-solid forming of shaped articles
GB9819898D0 (en)	1998-09-11	1998-11-04	Smithkline Beecham Plc	New vaccine and method of use
CA2773698C (en)	1998-10-16	2015-05-19	Glaxosmithkline Biologicals S.A.	Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof
EP1150712B1 (en) *	1999-02-05	2008-11-05	Merck & Co., Inc.	Human papilloma virus vaccine formulations
GB9921147D0 (en) *	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition

1999
- 1999-09-07 GB GB9921146A patent/GB9921146D0/en not_active Ceased
2000
- 2000-09-05 MY MYPI20004083A patent/MY130084A/en unknown
- 2000-09-05 AR ARP000104636 patent/AR025502A1/es active IP Right Grant
- 2000-09-05 MY MYPI20033661A patent/MY142842A/en unknown
- 2000-09-05 CO CO00066605A patent/CO5280045A1/es not_active Application Discontinuation
- 2000-09-06 GC GCP2000892 patent/GC0000201A/en active
- 2000-09-07 EP EP20000967654 patent/EP1210113B1/en not_active Expired - Lifetime
- 2000-09-07 DE DE2000627029 patent/DE60027029T2/de not_active Expired - Lifetime
- 2000-09-07 KR KR1020027003023A patent/KR100557665B1/ko not_active Expired - Fee Related
- 2000-09-07 CA CA 2443214 patent/CA2443214C/en not_active Expired - Lifetime
- 2000-09-07 ES ES03078635T patent/ES2253636T3/es not_active Expired - Lifetime
- 2000-09-07 NZ NZ52756000A patent/NZ527560A/xx not_active IP Right Cessation
- 2000-09-07 DK DK03078635T patent/DK1410805T3/da active
- 2000-09-07 CN CNB008154244A patent/CN100389824C/zh not_active Expired - Fee Related
- 2000-09-07 WO PCT/EP2000/008784 patent/WO2001017551A2/en not_active Ceased
- 2000-09-07 EP EP20060075129 patent/EP1769806A3/en not_active Withdrawn
- 2000-09-07 AT AT03078635T patent/ATE312624T1/de active
- 2000-09-07 IL IL14845600A patent/IL148456A0/xx not_active IP Right Cessation
- 2000-09-07 US US10/070,479 patent/US6936255B1/en not_active Expired - Fee Related
- 2000-09-07 CA CA 2384064 patent/CA2384064C/en not_active Expired - Fee Related
- 2000-09-07 ES ES00967654T patent/ES2261243T3/es not_active Expired - Lifetime
- 2000-09-07 BR BR0014171A patent/BR0014171A/pt not_active IP Right Cessation
- 2000-09-07 MX MXPA02002484A patent/MXPA02002484A/es active IP Right Grant
- 2000-09-07 HU HU0303215A patent/HU229099B1/hu unknown
- 2000-09-07 IL IL15810700A patent/IL158107A0/xx unknown
- 2000-09-07 PL PL362069A patent/PL201264B1/pl unknown
- 2000-09-07 NZ NZ517621A patent/NZ517621A/en unknown
- 2000-09-07 HK HK02108383.6A patent/HK1048435B/en not_active IP Right Cessation
- 2000-09-07 AU AU77751/00A patent/AU766494B2/en not_active Ceased
- 2000-09-07 JP JP2001521339A patent/JP4689910B2/ja not_active Expired - Fee Related
- 2000-09-07 HU HU0202804A patent/HU228687B1/hu not_active IP Right Cessation
- 2000-09-07 TR TR200200607T patent/TR200200607T2/xx unknown
- 2000-09-07 CZ CZ2002843A patent/CZ2002843A3/cs unknown
- 2000-09-07 DE DE2000624893 patent/DE60024893T2/de not_active Expired - Lifetime
- 2000-09-07 SI SI200030796T patent/SI1410805T1/sl unknown
- 2000-09-07 KR KR1020037013500A patent/KR100594668B1/ko not_active Expired - Lifetime
- 2000-09-07 ZA ZA200306402A patent/ZA200306402B/xx unknown
- 2000-09-07 SG SG200305672A patent/SG110072A1/en unknown
- 2000-09-07 SI SI200030859T patent/SI1210113T1/sl unknown
- 2000-09-07 EP EP20030078635 patent/EP1410805B1/en not_active Expired - Lifetime
- 2000-09-07 CN CNB2004100489635A patent/CN1325117C/zh not_active Expired - Lifetime
- 2000-09-07 CZ CZ20032326A patent/CZ302811B6/cs not_active IP Right Cessation
- 2000-09-07 AT AT00967654T patent/ATE321569T1/de active
- 2000-09-07 PT PT00967654T patent/PT1210113E/pt unknown
- 2000-09-07 PL PL354039A patent/PL201767B1/pl not_active IP Right Cessation
- 2000-09-07 DK DK00967654T patent/DK1210113T3/da active
- 2000-09-19 TW TW92125370A patent/TWI258374B/zh not_active IP Right Cessation
2002
- 2002-03-05 ZA ZA200201810A patent/ZA200201810B/xx unknown
- 2002-03-06 NO NO20021116A patent/NO332800B1/no not_active IP Right Cessation
2003
- 2003-08-20 JP JP2003296403A patent/JP2004067696A/ja active Pending
- 2003-08-21 NO NO20033715A patent/NO331825B1/no not_active IP Right Cessation
- 2003-09-25 IL IL158107A patent/IL158107A/en active IP Right Grant
- 2003-12-12 US US10/734,857 patent/US7101560B2/en not_active Expired - Lifetime
2006
- 2006-02-01 CY CY061100126T patent/CY1107457T1/el unknown
- 2006-06-05 CY CY20061100713T patent/CY1106090T1/el unknown
- 2006-06-29 US US11/477,879 patent/US7220551B2/en not_active Expired - Lifetime
2012
- 2012-10-08 NO NO2012016C patent/NO2012016I1/no unknown

Also Published As

Publication number	Publication date
PL354039A1 (en)	2003-12-15
HUP0202804A3 (en)	2004-08-30
NO332800B1 (no)	2013-01-14
IL148456A0 (en)	2002-09-12
TW200408405A (en)	2004-06-01
ATE321569T1 (de)	2006-04-15
HU229099B1 (en)	2013-07-29
CA2443214A1 (en)	2001-03-15
GC0000201A (en)	2006-03-29
US7220551B2 (en)	2007-05-22
CN1387443A (zh)	2002-12-25
KR100594668B1 (ko)	2006-06-30
US7101560B2 (en)	2006-09-05
CA2443214C (en)	2006-03-21
NO20021116L (no)	2002-04-30
JP2004067696A (ja)	2004-03-04
IL158107A0 (en)	2004-03-28
SI1410805T1 (sl)	2006-04-30
KR20030087081A (ko)	2003-11-12
ES2261243T3 (es)	2006-11-16
CZ302811B6 (cs)	2011-11-23
NO20033715D0 (no)	2003-08-21
PL201767B1 (pl)	2009-05-29
EP1210113B1 (en)	2006-03-29
NO2012016I2 (no)	2012-10-08
NO20021116D0 (no)	2002-03-06
PL201264B1 (pl)	2009-03-31
AU766494B2 (en)	2003-10-16
HK1064958A1 (en)	2005-02-08
JP2003508495A (ja)	2003-03-04
WO2001017551A2 (en)	2001-03-15
CN100389824C (zh)	2008-05-28
US6936255B1 (en)	2005-08-30
MXPA02002484A (es)	2002-08-28
MY142842A (en)	2011-01-14
EP1410805A1 (en)	2004-04-21
CY1106090T1 (el)	2011-06-08
EP1769806A3 (en)	2007-10-24
AR025502A1 (es)	2002-11-27
NO331825B1 (no)	2012-04-10
TWI258374B (en)	2006-07-21
DE60027029T2 (de)	2006-10-19
CY1107457T1 (el)	2012-12-19
PT1210113E (pt)	2006-07-31
JP4689910B2 (ja)	2011-06-01
SG110072A1 (en)	2005-04-28
NZ517621A (en)	2003-09-26
DK1410805T3 (da)	2006-04-18
US20060280756A1 (en)	2006-12-14
TR200200607T2 (tr)	2002-06-21
IL158107A (en)	2008-11-03
DK1210113T3 (da)	2006-07-03
HK1048435A1 (en)	2003-04-04
CA2384064C (en)	2010-06-01
EP1769806A2 (en)	2007-04-04
MY130084A (en)	2007-05-31
CO5280045A1 (es)	2003-05-30
CN1325117C (zh)	2007-07-11
BR0014171A (pt)	2002-05-21
US20040126394A1 (en)	2004-07-01
DE60024893D1 (de)	2006-01-19
SI1210113T1 (sl)	2006-08-31
DE60027029D1 (de)	2006-05-18
NZ527560A (en)	2004-12-24
NO20033715L (no)	2002-04-30
CA2384064A1 (en)	2001-03-15
NO2012016I1 (no)	2012-10-15
EP1210113A2 (en)	2002-06-05
HU0303215D0 (en)	2003-11-28
HUP0303215A3 (en)	2008-04-28
KR20020027630A (ko)	2002-04-13
DE60024893T2 (de)	2006-07-06
CZ2002843A3 (cs)	2002-08-14
HU228687B1 (en)	2013-05-28
HUP0202804A2 (hu)	2002-12-28
GB9921146D0 (en)	1999-11-10
AU7775100A (en)	2001-04-10
CN1618465A (zh)	2005-05-25
HK1048435B (en)	2007-01-05
EP1410805B1 (en)	2005-12-14
KR100557665B1 (ko)	2006-03-06
ZA200201810B (en)	2004-05-26
ES2253636T3 (es)	2006-06-01
WO2001017551A3 (en)	2001-09-27
ATE312624T1 (de)	2005-12-15

Publication	Publication Date	Title
ZA200201810B (en)	2004-05-26	Combined vaccine compositions.
EG24742A (en)	2010-07-14	Vaccine composition.
IL147647A0 (en)	2002-08-14	Vaccine composition
ZA200004956B (en)	2002-02-27	Vaccine composition.
ZA200003998B (en)	2000-08-14	Pharmaceutical compositions.
MXPA03008961A (es)	2004-02-12	Composicion de vacuna.
HUP0101047A3 (en)	2004-10-28	Combined vaccine compositions
MXPA01010676A (es)	2003-08-20	Composicion farmaceutica de vitamina d o un analogo de vitamina d y al menos un corticoesteroide.
ZA200108687B (en)	2003-03-26	Enhanced herbicide compositions.
GB9910812D0 (en)	1999-07-07	Vaccine composition
ZA200203486B (en)	2003-08-04	Novel pharmaceutical compositions.
ZA200108248B (en)	2002-12-24	Antiperspirant compositions.
MXPA01012478A (es)	2003-10-14	Formulaciones farmaceuticas mejoradas.
ZA200107149B (en)	2003-02-28	Valdecoxib compositions.
ZA200210359B (en)	2003-11-13	Pharmaceutical compositions.
ZA200000857B (en)	2001-05-31	Pharmaceutical composition.
MXPA03002105A (es)	2003-06-19	Composiciones farmaceuticas.
MXPA01010701A (es)	2003-08-20	Vacuna.
ZA200108844B (en)	2002-12-24	Fungicidal compositions.
ZA984696B (en)	1999-01-04	Vaccine compositions V.
AU1101701A (en)	2001-05-08	Vaccine compositions
GB9921347D0 (en)	1999-11-10	Novel immunogenic compositions
ZA200203986B (en)	2003-12-17	Vaccine compositions.
ZA200006204B (en)	2001-05-21	Polurethane/polyurea-forming compositions.
GB9929434D0 (en)	2000-02-09	Novel vaccine composition